Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis

被引:129
作者
George, J [1 ]
Herz, I
Goldstein, E
Abashidze, S
Deutch, V
Finkelstein, A
Michowitz, Y
Miller, H
Keren, G
机构
[1] Tel Aviv Sourasky Med Ctr, Dept Cardiol, Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Inst Hematol, Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
endothelial progenitor cell; stem-cell; restenosis; stent; endothelium;
D O I
10.1161/01.ATV.0000107029.65274.db
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Intact endothelialization machinery is essential to facilitate vessel healing after stent placement and to prevent restenosis. Circulating endothelial progenitor cells (EPC) have been demonstrated in the peripheral blood and shown to display endothelial functional properties, along with the ability to traffic to damaged vasculature. We reasoned that robust in-stent intimal growth could be partially related to impaired endothelialization resulting from reduced circulating EPC number or function. Methods and Results - Sixteen patients with angiographically- demonstrated in-stent restenosis were compared with patients with a similar clinical presentation that exhibited patent stents(n = 11). Groups were similar with respect to the use of drugs that could potentially influence EPC numbers. Circulating EPC numbers were determined by the colony-forming unit assay, and their phenotype was characterized by endothelial-cell markers. Adhesiveness of EPC from both groups to extracellular matrix and to endothelial cells was also assayed. Patients with in-stent restenosis and with patent stents displayed a similar number of circulating EPC. Fibronectin-binding was compromised in patients with in-stent restenosis as compared with their controls exhibiting patent stents. Patients with diffuse in-stent restenosis exhibited reduced numbers of EPC in comparison with subjects with focal in-stent lesions. Conclusion - Reduced numbers of circulating EPC in patients with diffuse in-stent restenosis and impaired adhesion of EPC from patients with restenosis provides a potential mechanism mediating the exuberant proliferative process. These markers, if further validated, could provide means of risk stratifying patients for likelihood of developing in-stent restenosis.
引用
收藏
页码:E57 / E60
页数:4
相关论文
共 15 条
  • [1] Isolation of putative progenitor endothelial cells for angiogenesis
    Asahara, T
    Murohara, T
    Sullivan, A
    Silver, M
    vanderZee, R
    Li, T
    Witzenbichler, B
    Schatteman, G
    Isner, JM
    [J]. SCIENCE, 1997, 275 (5302) : 964 - 967
  • [2] Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction -: (TOPCARE-AMI)
    Assmus, B
    Schächinger, V
    Teupe, C
    Britten, M
    Lehmann, R
    Döbert, N
    Grünwald, F
    Aicher, A
    Urbich, C
    Martin, H
    Hoelzer, D
    Dimmeler, S
    Zeiher, AM
    [J]. CIRCULATION, 2002, 106 (24) : 3009 - 3017
  • [3] The biology of restenosis
    Bauters, C
    Isner, JM
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1997, 40 (02) : 107 - 116
  • [4] Drug-eluting stents in vascular intervention
    Fattori, R
    Piva, T
    [J]. LANCET, 2003, 361 (9353) : 247 - 249
  • [5] Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
    Hill, JM
    Zalos, G
    Halcox, JPJ
    Schenke, WH
    Waclawiw, MA
    Quyyumi, AA
    Finkel, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) : 593 - 600
  • [6] Endothelial progenitor cells - Mobilization, differentiation, and homing
    Hristov, M
    Erl, W
    Weber, PC
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (07) : 1185 - 1189
  • [7] Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
    Kalka, C
    Masuda, H
    Takahashi, T
    Kalka-Moll, WM
    Silver, M
    Kearney, M
    Li, T
    Isner, JM
    Asahara, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3422 - 3427
  • [8] HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells
    Llevadot, J
    Murasawa, S
    Kureishi, Y
    Uchida, S
    Masuda, H
    Kawamoto, A
    Walsh, K
    Isner, JM
    Asahara, T
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) : 399 - 405
  • [9] Aging, progenitor cell exhaustion, and atherosclerosis
    Rauscher, FM
    Goldschmidt-Clermont, PJ
    Davis, BH
    Tang, W
    Gregg, D
    Ramaswami, R
    Pippen, AM
    Annex, BH
    Dong, CM
    Taylor, DA
    [J]. CIRCULATION, 2003, 108 (04) : 457 - 463
  • [10] Mobilization of endothelial progenitor cells in patients with acute myocardial infarction
    Shintani, S
    Murohara, T
    Ikeda, H
    Ueno, T
    Honma, T
    Katoh, A
    Sasaki, KI
    Shimada, T
    Oike, Y
    Imaizumi, T
    [J]. CIRCULATION, 2001, 103 (23) : 2776 - 2779